FREQ News and Press, Frequency Therapeutics Inc.

2023-08-21 11:52:45 ET More on Health Care Select Sector SPDR XLV Vs. VHT: A Head-To-Head Healthcare ETF Comparison XLV: The Powerhouse ETF Driving Health And Wealth BlackRock spotlights healthcare as an opportunity with recession talks in the air Goldman add...

Frequency Therapeutics, Inc. (Nasdaq: FREQ) today announced business updates and financial results for the second quarter ended June 30, 2023. In July, the Company announced that it entered into a definitive merger agreement with Korro Bio, Inc., a leading RNA editing company focused on the d...

2023-07-15 06:36:00 ET 3 Things to Know About Using Analyst Opinions for Trading Penny Stocks Trading penny stocks can be a thrilling venture, offering the potential for significant returns on small investments. One of the key aspects that can influence the success of such trades is the...

Merger to create a Nasdaq-listed genetic medicines company focused on advancing Korro Bio’s wholly owned portfolio of RNA editing programs Lead program is a disease modifying therapy for patients with alpha-1 antitrypsin deficiency (AATD), with preclinical data showing an increase ...

2023-06-07 12:13:30 ET Frequency Therapeutics ( NASDAQ: FREQ ) said it is reducing its workforce by ~55%, with the board having approved the planned layoffs. The biotechnology company said it intends to better align its workforce with the changing needs of business. Th...

2023-05-12 16:21:50 ET Frequency Therapeutics press release ( NASDAQ: FREQ ): Q1 GAAP EPS of -$0.55 misses by $0.11 . As of March 31, 2023, Frequency had cash, cash equivalents and marketable securities of $66.7 million, or $55.0 million net of debt. In April, the Comp...

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced business updates and financial results for the first quarter ended March 31, 2023. “We are...

VANCOUVER, BC / ACCESSWIRE / May 10, 2023 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is excited to announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), has signed its first White Label Agreement. The FREmedica bioenergetic freq...

VANCOUVER, BC / ACCESSWIRE / March 30, 2023 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) pleased to announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), has been approved for its new App "NIKKI CONNECT" to be registered with bo...

2023-03-10 07:53:54 ET Frequency Therapeutics press release ( NASDAQ: FREQ ): Q4 GAAP EPS of -$0.49 beats by $0.14 . As of December 31, 2022, Frequency had cash, cash equivalents and marketable securities of $83.1 million (excluding restricted cash), or $68.9 million n...